Self-perceived stress among young women was significantly associated with increased risk for early-onset cryptogenic ischemic ...

A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

In summary, mini-strokes happen when blood flow to the brain is briefly interrupted. The main causes include blood clots, narrowed arteries, high blood pressure, diabetes, and unhealthy lifestyle ...

Stroke, (paralysis) or a brain attack is a disabling brain disorder that affects more than 20 million people across the world ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Ischemic stroke is a fatal condition caused by an arterial embolism that blocks the blood flow through the cerebral artery, frequently being a cause of mortality and disability. Fibroblast growth ...

Since brain damage occurs and progresses rapidly during an acute ischemic stroke, immediate, fast-acting medical care is vital. “Today’s approval is a significant step forward and underscores ...

MicroTransponder has received $65m in a Series F financing round, which aims to enhance its stroke care offerings with the ...

Perfuze, a medtech has raised €22m. With the infusion, the company will release its catheters to select stroke centres in the US.

Researchers at the University of Maryland identified a potential link between early-onset ischemic stroke and a genetic ...

Researchers at the University of Maryland (UMD) have revealed the blood type with which a person is at risk of suffering a ...